J. David Jacobs

J. David Jacobs, JD has led the legal work on well more than 100 acquisitions, spin-outs, dispositions, mergers, and follow-on transactions, and has represented more than 50 operating companies across a wide range of healthcare and life sciences, including drug development, contract research (CROs), contract manufacturing (CDMOs), device, component and instrument manufacture, development and clinical testing laboratories, tissue engineering and gene sequencing and synthesis vendors. His work includes commercial transactions, board support, employee matters, dispute resolution, real estate, financings and licensing.

Prior to establishing his law practice, Mr. Jacobs served as General Counsel to Ampersand Capital Partners from 2005 to 2011, and to several Ampersand portfolio companies and non-Ampersand companies. Previously, David was General Counsel of ArQule (Nasdaq: ARQL), where he also served as Chief Compliance Officer. Prior to ArQule, David served as the business lawyer for the Biomedical Services division of the American Red Cross. David’s work for the $1.5 billion revenue Blood, Plasma and Tissue divisions of the Red Cross focused on international joint ventures, licensing, M&A, and commercial agreements. Prior to joining the Red Cross, David practiced in the fields of tax and international transactions at prestigious law firms in New York and Jerusalem.

David holds a J.D. from Columbia Law School as a Harlan Fiske Stone Scholar, an M.A. with distinction in Talmud from the Jewish Theological Seminary and a B.A. from Columbia (Middle East studies).